Leucocyte telomere length in patients with sickle cell disease

British Journal of Haematology

Volumn 165, Issue 5, 2014, Pages 725-727

  Drašar, Emma R ^a,b   Jiang, Jie ^a   Gardner, Kate ^a,b   Howard, Jo ^c   Vulliamy, Tom ^d   Vasavda, Nisha ^a   Thein, Swee Lay ^a,b  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Inflammation; Sickle cell disease; Telomere

Indexed keywords

ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DETERMINATION; DNA ISOLATION; FEMALE; GENE AND NUCLEIC ACID PARAMETERS; HUMAN; LETTER; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEUTROPHIL COUNT; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STRUCTURAL GENOMICS; TELOMERE; TELOMERE LENGTH; AGING; CASE CONTROL STUDY; CHILD; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TELOMERE HOMEOSTASIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; TELOMERE HOMEOSTASIS; YOUNG ADULT;

EID: 84900481712     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12776     Document Type: Letter

References (10)

1. Blackburn, E.H. (2010) Telomeres and telomerase: the means to the end (Nobel lecture). Angewandte Chemie (International ed. in English), 49, 7405-7421.
2. Calado, R.T. & Young, N.S. (2009) Telomere diseases. New England Journal of Medicine, 361, 2353-2365.
3. Cawthon, R.M. (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Research, 37, e21.
4. Chirico, E.N. & Pialoux, V. (2012) Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life, 64, 72-80.
5. Field, J.J., Lin, G., Okam, M.M., Majerus, E., Keefer, J., Onyekwere, O., Ross, A., Campigotto, F., Neuberg, D., Linden, J. & Nathan, D.G. (2013) Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood, 121, 3329-3334.
6. Fitzpatrick, A.L., Kronmal, R.A., Gardner, J.P., Psaty, B.M., Jenny, N.S., Tracy, R.P., Walston, J., Kimura, M. & Aviv, A. (2007) Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. American Journal of Epidemiology, 165, 14-21.
7. Hebbel, R.P., Osarogiagbon, R. & Kaul, D. (2004) The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation, 11, 129-151.
8. Lanaro, C., Franco-Penteado, C.F., Albuqueque, D.M., Saad, S.T., Conran, N. & Costa, F.F. (2009) Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. Journal of Leukocyte Biology, 85, 235-242.
9. Nagel, R.L., Fabry, M.E. & Steinberg, M.H. (2003) The paradox of hemoglobin SC disease. Blood Reviews, 17, 167-178.
10. Platt, O.S. (2000) Sickle cell anemia as an inflammatory disease. The Journal of Clinical Investigation, 106, 337-338.